Roche's Foundation Medicine wins FDA blessing for new cancer test

ZURICH (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumors and guide them to effective therapies.